(Q39270988)

English

Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model

scientific article

Statements

Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model (English)
Arne R M van der Bilt
Anton G T Terwisscha van Scheltinga
Hetty Timmer-Bosscha
Carolien P Schröder
Linda Pot
Jos G W Kosterink
Ate G J van der Zee
Marjolijn N Lub-de Hooge
Steven de Jong
Anna K L Reyners
26 September 2012
6306-6314

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit